ST Pharm saw the highest growth of 0.49% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of ST Pharm’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
ST Pharm has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with two publications in Q2 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 67% of filings. The World Intellectual Property Organization(WIPO), South Korea(KR), and China(CN) patent Office are among the top ten patent offices where ST Pharm is filings its patents. Among the top granted patent authorities, ST Pharm has 100% of its grants in China(CN).
Gilead Sciences and GSK could be the strongest competitors for ST Pharm
Patents related to nanomedicine and cell & gene therapy lead ST Pharm's portfolio
ST Pharm has the highest number of patents in nanomedicine followed by, cell & gene therapy and 3d printing. For nanomedicine, nearly 40% of patents were filed and no patents were granted in Q2 2024.
For comprehensive analysis of ST Pharm's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
